Follow
Javier Aller
Javier Aller
Hospital Universitario Puerta de Hierro Majadahonda
Verified email at salud.madrid.org
Title
Cited by
Cited by
Year
Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene
A Cascón, I Comino-Méndez, M Currás-Freixes, AA de Cubas, ...
Journal of the National Cancer Institute 107 (5), djv053, 2015
2382015
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
M Currás-Freixes, L Inglada-Pérez, V Mancikova, C Montero-Conde, ...
Journal of medical genetics 52 (10), 647-656, 2015
1212015
Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas
L Remacha, D Pirman, CE Mahoney, J Coloma, B Calsina, ...
The American Journal of Human Genetics 104 (4), 651-664, 2019
822019
PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics
M Currás-Freixes, E Piñeiro-Yañez, C Montero-Conde, M Apellániz-Ruiz, ...
The Journal of Molecular Diagnostics 19 (4), 575-588, 2017
692017
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma
B Calsina, LJ Castro-Vega, R Torres-Pérez, L Inglada-Pérez, ...
Theranostics 9 (17), 4946, 2019
572019
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
P Jiménez-Fonseca, A Carmona-Bayonas, E Martín-Pérez, G Crespo, ...
Cancer and Metastasis Reviews 34, 381-400, 2015
572015
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in …
R Garcia-Carbonero, R Garcia-Figueiras, A Carmona-Bayonas, I Sevilla, ...
Cancer and Metastasis Reviews 34, 823-842, 2015
502015
Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up
P Valderrábano, J Aller, L García-Valdecasas, J García-Uría, L Martín, ...
Endocrinología y Nutrición (English Edition) 61 (4), 176-183, 2014
452014
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience
G Crespo, P Jiménez-Fonseca, A Custodio, C López, ...
Future Oncology 13 (7), 615-624, 2017
442017
No clinically significant valvular regurgitation in long‐term cabergoline treatment for prolactinoma
I Halperin, J Aller, C Varela, M Mora, A Abad, A Doltra, AE Santos, ...
Clinical endocrinology 77 (2), 275-280, 2012
392012
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer
J Capdevila, K Newbold, L Licitra, A Popovtzer, F Moreso, J Zamorano, ...
Cancer Treatment Reviews 69, 164-176, 2018
372018
A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly
PJ Trainer, JDC Newell-Price, J Ayuk, SJB Aylwin, A Rees, W Drake, ...
European Journal of Endocrinology 179 (2), 97-108, 2018
352018
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)
J Capdevila, JM Trigo, J Aller, JL Manzano, SG Adrián, CZ Llopis, Ò Reig, ...
European Journal of Endocrinology 177 (4), 309-317, 2017
352017
Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment
M Campderá, N Palacios, J Aller, R Magallón, P Martín, G Saucedo, ...
Pituitary 19, 158-166, 2016
352016
Pasireotide in the personalized treatment of acromegaly
M Puig-Domingo, I Bernabéu, A Picó, B Biagetti, J Gil, C Alvarez-Escolá, ...
Frontiers in Endocrinology 12, 648411, 2021
302021
Translational research in neuroendocrine tumors: pitfalls and opportunities
J Capdevila, O Casanovas, R Salazar, D Castellano, A Segura, P Fuster, ...
Oncogene 36 (14), 1899-1907, 2017
292017
Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus
I Bernabeu, J Aller, C Álvarez-Escolá, C Fajardo-Montañana, ...
Endocrinología, Diabetes y Nutrición (English ed.) 65 (5), 297-305, 2018
272018
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
I Bernabeu, A Pico, E Venegas, J Aller, C Alvarez-Escolá, ...
Pituitary 19, 127-137, 2016
272016
Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma
C Rodriguez-Antona, I Muñoz, L Inglada-Perez, AA de Cubas, ...
Endocrine-related cancer, 2013
212013
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre S panish study
G Sesmilo, E Resmini, I Bernabeu, J Aller, A Soto, M Mora, A Picó, ...
Clinical endocrinology 81 (6), 883-890, 2014
202014
The system can't perform the operation now. Try again later.
Articles 1–20